Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume → Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad) Free GRTX Stock Alerts $0.18 0.00 (-1.08%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Galera Therapeutics Short Interest DataCurrent Short Volume1,770,000 sharesPrevious Short Volume2,800,000 sharesChange Vs. Previous Month-36.79%Dollar Volume Sold Short$247,800.00Short Interest Ratio / Days to Cover0.7Last Record DateMarch 31, 2024Outstanding Shares54,390,000 sharesFloat Size43,530,000 sharesShort Percent of Float4.07%Today's Trading Volume800,599 sharesAverage Trading Volume2,436,943 sharesToday's Volume Vs. Average33% Short Selling Galera Therapeutics ? Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGRTX Short Interest Over TimeGRTX Days to Cover Over TimeGRTX Percentage of Float Shorted Over Time Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Galera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14 3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21 2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24 2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18 1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18 1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22 Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15 12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14 11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14 11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14 10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10 10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19 9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18 9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19 8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21 8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27 7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46 7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75 6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12 6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39 5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07 5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18 10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45 10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55 9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74 9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87 8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34 8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46 7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16 7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20 6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30 6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48 5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60 5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51 4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69 4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13 3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38 3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10 2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24 2/15/2022297,000 shares $694,980.00 +93.7%1.7%0 $2.34Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> GRTX Short Interest - Frequently Asked Questions What is Galera Therapeutics' current short interest? Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 1,770,000 shares of GRTX short. 4.07% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest. What is a good short interest ratio for Galera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRTX shares currently have a short interest ratio of 1.0. Learn More on Galera Therapeutics's short interest ratio. Which institutional investors are shorting Galera Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Galera Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Galera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.07% of Galera Therapeutics' floating shares are currently sold short. Is Galera Therapeutics' short interest increasing or decreasing? Galera Therapeutics saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,770,000 shares, a decrease of 36.8% from the previous total of 2,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galera Therapeutics' float size? Galera Therapeutics currently has issued a total of 54,390,000 shares. Some of Galera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galera Therapeutics currently has a public float of 43,530,000 shares. How does Galera Therapeutics' short interest compare to its competitors? 4.07% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Galera Therapeutics: Biofrontera Inc. (0.95%), Akari Therapeutics, Plc (0.16%), Adial Pharmaceuticals, Inc. (0.24%), Aeterna Zentaris Inc. (0.45%), Alterity Therapeutics Limited (0.28%), Molecular Templates, Inc. (1.15%), Longeveron Inc. (3.10%), Hepion Pharmaceuticals, Inc. (1.47%), Moleculin Biotech, Inc. (2.09%), Virios Therapeutics, Inc. (1.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Galera Therapeutics stock? Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. GRTX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galera Therapeutics? A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further. How often is Galera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: BFRI Short Interest AKTX Short Interest ADIL Short Interest AEZS Short Interest ATHE Short Interest MTEM Short Interest LGVN Short Interest HEPA Short Interest MBRX Short Interest VIRI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative